Akebia Therapeutics, Inc. (AKBA) Competitors & Peers
The 5 companies closest to Akebia Therapeutics, Inc. on the factors that matter — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| JHPCY | Peer | $13.60 | P/E 37.8RSI 7Cap 45.1 B |
| GDERF | Peer | $228.55 | P/E 62.4RSI 56Cap 53.3 B |
| TAK | Peer | $17.55 | RSI 61Cap 56.0 B |
| GALDY | Peer | $43.24 | P/E 59.2RSI 50Cap 50.4 B |
| TKPHF | Peer | $35.89 | RSI 66Cap 57.3 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- CAHSupplier
Own 10-K customer-concentration disclosure: CardinalHealthInc = 10% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - MCKSupplier
Own 10-K customer-concentration disclosure: McKessonCorporation = 12% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗ - 4578.TSupplier
Own 10-K customer-concentration disclosure: OtsukaPharmaceuticalCompanyLimited = 0% of revenue.
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- IQVPartner
IQVIA provides contract clinical research and trial management services (CRO).
Model-inferred, unverified — treat as a lead, not evidence - AMZNSupplier
Utilizes AWS cloud infrastructure to host genomic sequencing data and clinical trial databases.
Model-inferred, unverified — treat as a lead, not evidence - PFECompetitor
Competes in development and commercialization of therapeutics for similar indications.
Model-inferred, unverified — treat as a lead, not evidence